NCT03959891 2025-09-29AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)Massachusetts General HospitalPhase 1 Active not recruiting77 enrolled